
Lithium vs. Quetiapine: Augmenting Treatment-Resistant Depression
Psychopharmacology and Psychiatry Updates
00:00
Study Rationale and Design
Paul Zarkowski explains why the UK open-label trial compared lithium and quetiapine for treatment-resistant depression.
Play episode from 01:55
Transcript


